Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.50
Delayed Data
As of 3:59pm ET
 -0.13 / -1.35%
Today’s Change
6.96
Today|||52-Week Range
25.25
-45.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues18.7M43.4M20.8M52.2M
 
 
 
 
 
Cost of Goods Sold6.1M7.7M5.8M8.0M
 
 
 
 
 
Depreciation And Amortization421.0K395.0K402.0K459.0K
 
 
 
 
 
 
Operating ExpensesGross Income12.2M35.2M14.6M43.8M
 
 
 
 
 
General Expenses26.1M31.0M37.8M38.3M
 
 
 
 
 
Research And Development16.7M21.2M27.6M27.7M
 
 
 
 
 
Total Operating Expenses32.6M39.2M44.0M46.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.9M4.2M-23.2M5.5M
 
 
 
 
 
Interest Expense On Debt1.3M1.3M1.3M1.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.1M3.0M-24.5M4.3M
 
 
 
 
 
Net Income-15.1M3.0M-24.5M4.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS125.3M126.1M126.9M127.2M
 
 
 
 
 
Shares To Calculate EPS Diluted125.3M134.5M126.9M129.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12$0.02-$0.19$0.03
 
 
 
 
 
EPS Diluted-$0.12$0.02-$0.19$0.03